Sign in

You're signed outSign in or to get full access.

Amy Lancellotta

About Amy B. R. Lancellotta

Independent Board Member of the Nuveen funds complex (including NAZ) since 2021; Class II term runs until the 2026 annual meeting. Former Managing Director of the Independent Directors Council (IDC) at the Investment Company Institute (ICI) from 2006–2019, with earlier roles at ICI (from 1989) and prior law-firm associate experience; B.A. (Penn State, 1981) and J.D. (George Washington University Law Center, 1984); year of birth 1959. Governance/regulatory specialist with decades of fund governance leadership and policy engagement experience.

Past Roles

OrganizationRoleTenure/NotesCommittees/Impact
Independent Directors Council (IDC), ICIManaging Director2006–2019; led education, communication, governance, and policy initiatives for independent fund directorsAdvised IDC/ICI and fund directors on governance and regulatory matters
Investment Company Institute (ICI)Various positions1989–2006Industry policy and governance expertise
Washington, D.C. law firmsAssociateNot disclosed (prior to 1989)Legal foundation in securities/financial services

External Roles

OrganizationRoleTenure/Notes
Jewish Coalition Against Domestic Abuse (JCADA)President (since 2023); Board Member (since 2020)Non-profit governance and leadership role

Board Governance

  • Independence: Identified among directors “who are not ‘interested persons’” (Independent Board Member). All relevant committees on which she serves are composed entirely of Independent Board Members.
  • Board structure: Board led by an Independent Chair (Robert L. Young).
  • Term and tenure: Class II director, term through the 2026 annual meeting; service since 2021. Oversees 220 portfolios in the fund complex.
  • Committee assignments and roles:
    • Investment Committee – Co-Chair (Board-wide oversight of fund performance, investment risks, leverage/hedging)
    • Audit Committee – Member (financial statements, auditor independence, valuation oversight)
    • Nominating & Governance Committee – Member (director qualifications, independence, board composition)
    • Dividend Committee – Member (distribution policy and declarations)
CommitteeRoleIndependence/Charter
InvestmentCo-ChairComposed of Independent Board Members; chartered oversight of performance and investment risk
AuditMemberComposed of Independent Board Members; SEC/NYSE/NASDAQ independence requirements met; valuation oversight included
Nominating & GovernanceMemberComposed entirely of Independent Board Members
DividendMemberCharter governs distributions; membership listed in proxy

Fixed Compensation

  • Structure (pre- and post-2025): Independent directors are paid cash retainers, committee membership and chair fees, with ad hoc/special assignment fees; no pension; optional deferred compensation plan to mirror Nuveen fund returns on deferred amounts.
ComponentThrough Dec 31, 2024Effective Jan 1, 2025
Annual Board Retainer$350,000 $350,000
Audit Committee – Member$30,000 $35,000
Compliance, Risk Mgmt & Regulatory Oversight – Member$30,000 $35,000
Investment Committee – Member$20,000 $30,000
Dividend Committee – Member$20,000 $25,000
Nominating & Governance – Member$20,000 $25,000
Closed-End Funds Committee – Member$20,000 $25,000
Independent Chair of the Board$140,000 $150,000
Audit Committee – Chair$30,000 $35,000
Compliance Committee – Chair$30,000 $35,000
Investment Committee – Chair/Co-Chair$20,000 $30,000
Dividend Committee – Chair$20,000 $25,000
Nominating & Governance – Chair$20,000 $25,000
Closed-End Funds Committee – Chair$20,000 $25,000
Ad hoc meeting fee$1,000 or $2,500 per meeting $1,000 or $2,500 per meeting
Special assignment committee – Chair (quarterly)From $1,250 From $1,250
Special assignment committee – Member (quarterly)From $5,000 From $5,000
Retirement/PensionNone (no retirement or pension plans) None (no retirement or pension plans)
Deferred CompensationPlan available; deferrals track designated Nuveen funds; lump sum or 2–20 year distribution options Plan available; deferrals track designated Nuveen funds; lump sum or 2–20 year distribution options
FY Aggregate Compensation (Fund Complex)Amount
Total compensation from Nuveen funds paid to Amy B. R. Lancellotta$469,250

Performance Compensation

Independent directors receive fixed retainers and committee fees; the proxy discloses no bonus, stock, option, or performance-linked compensation elements for directors.

ComponentDisclosure
Target bonus % / Actual bonusNot disclosed for independent directors; compensation described as retainers/fees
Stock awards (RSUs/PSUs)Not disclosed for independent directors
Option awardsNot disclosed for independent directors
Performance metrics (revenue, EBITDA, TSR, ESG)Not applicable/disclosed for independent directors
Clawback provisionsNot disclosed for directors; deferred compensation mechanics disclosed

Other Directorships & Interlocks

TypeCompany/OrganizationRoleNotes
Public company boardsNone disclosedNo public company directorships listed for Lancellotta in the proxy’s director biographies
Non-profitJCADAPresident; DirectorMember since 2020; President since 2023
Interlocks/conflictsNone disclosedNo disclosed shared directorships with NAZ competitors/suppliers/customers

Expertise & Qualifications

  • Fund governance and regulation: Led IDC at ICI, advising independent directors and coordinating governance/policy initiatives.
  • Legal/regulatory background: J.D.; prior law firm associate; extensive engagement with regulatory/industry bodies via ICI/IDC.
  • Board oversight experience: Co-Chairs the Investment Committee; serves on Audit, Nominating & Governance, and Dividend Committees.

Equity Ownership

  • Board investment principle: Each Board Member is expected to invest, directly or on a deferred basis, at least the equivalent of one year of compensation in funds within the fund complex. The proxy provides only dollar-range ownership disclosures and does not quantify exact amounts per director.
  • Ownership as % of outstanding: As of Oct 22, 2025, each Board Member’s holdings in each fund were less than 1% of that fund’s outstanding shares.
MetricSep 20, 2024Oct 22, 2025
Shares in NAZ (Arizona Quality)0 $0 range; 0 shares reported separately in 2024 table; 2025 table shows $0 range per fund
Shares in California AMT-Free0 $0 range
Shares in California Value0 $0 range
Shares in California Quality0 $0 range
Shares in Massachusetts Quality0 $0 range
Aggregate range across Nuveen funds overseenOver $100,000 Over $100,000
Ownership as % of each fund’s outstandingNot disclosed<1% for each fund (board-wide)

Notes: The aggregate range disclosure (“Over $100,000”) is across all registered investment companies overseen, not specific to NAZ. Compliance with the “one year of compensation” expectation cannot be determined from dollar-range disclosures alone.

Governance Assessment

  • Strengths
    • Deep fund governance expertise (former IDC Managing Director) aligns with oversight needs of a closed-end fund; enhances board effectiveness on policy and shareholder-protection matters.
    • Significant committee workload and leadership (Co-Chair, Investment Committee; member of Audit, Nominating & Governance, Dividend) indicates high engagement and influence over investment risk, valuation, and governance.
    • Board and committees emphasize independence; Board led by an Independent Chair; relevant committees composed solely of independent members.
  • Alignment and incentives
    • Cash-based compensation structure with standardized retainers/fees; optional deferred compensation aligns economics with Nuveen fund performance when elected.
    • Board principle expects each director to invest at least one year of compensation in the fund complex; Lancellotta’s reported aggregate holdings are “Over $100,000,” but exact compliance cannot be verified from range-only data. Monitoring item for ownership alignment transparency.
  • Conflicts and related-party exposure
    • No related-party transactions disclosed for Lancellotta (affiliate investment holdings table shows another director, not Lancellotta).
  • Compensation changes
    • 2025 increases to several committee membership/chair fees and Board Chair fee; reflects board-wide adjustments rather than individual anomalies.
  • RED FLAGS
    • None specifically disclosed for Lancellotta regarding attendance, related-party transactions, hedging/pledging, or performance pay anomalies. Ownership disclosure is in ranges, limiting verification of compliance with the board’s investment expectation.

Citations:

  • 2025 Proxy (DEF 14A, Nov 6, 2025): independence/committees/compensation/ownership/governance
  • 2024 Proxy (DEF 14A, Oct 17, 2024): biography/ownership history/committee context